Class Generic Claims. To the extent AstraZeneca intends to make any claims in a Product label that are class generic to microRNA Compounds, AstraZeneca will provide such claims to Regulus in advance and will take into account any proposals and comments made by Regulus.
Appears in 2 contracts
Sources: Collaboration and License Agreement, Collaboration and License Agreement (Regulus Therapeutics Inc.)